EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

MiR-92a regulates PTEN/Akt signaling axis to promote paclitaxel resistance in ovarian cancer cells

Xiujuan Deng, Haigen Wu, Liping Xiong, Mouxi Wu, Jinfu Cao, Jing Liu, Wenyang Xie

Acta Biochimica Polonica · 03.02.2023

DOI: 10.18388/abp.2020_6412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica Polonica, online erschienen am 03.02.2023. Verfasst von Xiujuan Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology, Jiujiang Maternal and Child Health Hospital. Jiujiang, Jiangxi 332000, China. Hauptthemen laut MEDLINE: MicroRNAs, Ovarian Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To investigate the function and possible mechanism of miR-92a in malignant behaviors such as paclitaxel resistance in ovarian cancer (OC) cells. The miR-92a and PTEN expression were detected by real-time PCR (RT-PCR). The cell viability and apoptosis were detected by MTT, colony formation and flow cytometry assay, respectively. Dual-luciferase reporter assay was adopted to verify the targeting relationship between miR-92a and PTEN. Besides, we measured the relative protein levels of PTEN and p-AKT/AKT by Western blot. MiR-92a was significantly highly expressed in OC cells, and its high expression could notably enhance paclitaxel resistance, cell proliferation and colony formation, as well as inhibit apoptosis in SKOV3-Tax cells. Further luciferase reporter assay and expression detection showed that miR-92a could target and regulate PTEN and that there was a targeted relationship between them. In addition, further exploration of the mechanism revealed that miR-92a regulated PTEN/Akt signaling pathway. MiR-92a not only promotes the proliferation, colony formation and paclitaxel resistance of SKOV3-Tax cells in OC, but also inhibits apoptosis, and it may be related to the regulation of the PTEN/Akt signaling pathway. MiR-92a serves as a potential biomarker for the malignant biological behavior of OC cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsOvarian NeoplasmsHumansFemalePaclitaxelProto-Oncogene Proteins c-aktSignal TransductionCell Line, TumorCell ProliferationApoptosisPTEN Phosphohydrolase

Substanzen

PaclitaxelProto-Oncogene Proteins c-aktMicroRNAsPTEN protein, humanPTEN Phosphohydrolase

Autor:innen und Institutionen

  • Department of Gynaecology, Jiujiang Maternal and Child Health Hospital. Jiujiang, Jiangxi 332000, China.
  • Department of Obstetrics and Gynecology, De'an County People's Hospital. Jiujiang, Jiangxi 330499, China.
  • Department of Obstetrics and Gynecology, Jiujiang Maternal and Child Health Hospital. Jiujiang, Jiangxi 332000, China.

Zitieren

APA

Deng, X., Wu, H., Xiong, L., Wu, M., Cao, J., Liu, J., & Xie, W. (2023). MiR-92a regulates PTEN/Akt signaling axis to promote paclitaxel resistance in ovarian cancer cells. Acta Biochimica Polonica. https://doi.org/10.18388/abp.2020_6412

Vancouver

Deng X, Wu H, Xiong L, Wu M, Cao J, Liu J, et al. MiR-92a regulates PTEN/Akt signaling axis to promote paclitaxel resistance in ovarian cancer cells. Acta Biochimica Polonica. 2023. doi:10.18388/abp.2020_6412

BibTeX
@article{Deng2023,
  author = {Deng, Xiujuan and Wu, Haigen and Xiong, Liping and Wu, Mouxi and Cao, Jinfu and Liu, Jing and Xie, Wenyang},
  title = {MiR-92a regulates PTEN/Akt signaling axis to promote paclitaxel resistance in ovarian cancer cells},
  journal = {Acta Biochimica Polonica},
  year = {2023},
  doi = {10.18388/abp.2020_6412}
}
Kostenlos starten →